These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 7920500

  • 1. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD, Lambert R, Capron MH.
    Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal antiinflammatory drug therapy in elderly patients. A multicenter double-blind, placebo-controlled trial.
    Piette F, Teillet L, Naudin R, Boichut D, Capron MH.
    Rev Rhum Engl Ed; 1997 Apr; 64(4):259-66. PubMed ID: 9178399
    [Abstract] [Full Text] [Related]

  • 4. Diclofenac/misoprostol: the European clinical experience.
    McKenna F.
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [Abstract] [Full Text] [Related]

  • 5. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

  • 6. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ, Karrasch JA, Szczepañski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND.
    N Engl J Med; 1998 Mar 12; 338(11):727-34. PubMed ID: 9494149
    [Abstract] [Full Text] [Related]

  • 7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 12; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 8. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
    Roth SH.
    J Rheumatol Suppl; 1990 Feb 12; 20():20-4. PubMed ID: 2109073
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG.
    Am J Gastroenterol; 1991 Dec 12; 86(12):1743-8. PubMed ID: 1962619
    [Abstract] [Full Text] [Related]

  • 10. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Dec 12; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 11. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 12; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 13. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ, Schnell TG, Budiman-Mak E, Adelman K, Fleischmann R, Cohen S, Roth SH, Ipe D, Schwartz KE.
    Am J Gastroenterol; 1994 Jul 29; 89(7):1014-20. PubMed ID: 8017358
    [Abstract] [Full Text] [Related]

  • 14. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G.
    Am J Gastroenterol; 1996 Nov 29; 91(11):2367-71. PubMed ID: 8931419
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 29; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 16. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A, Alvisi V, Blasi A, Dobrilla G, Fioravanti A, Marcolongo R.
    Ital J Gastroenterol; 1991 Mar 29; 23(3):119-23. PubMed ID: 1742504
    [Abstract] [Full Text] [Related]

  • 17. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM, Aziz K.
    J Rheumatol Suppl; 1998 May 29; 51():17-20. PubMed ID: 9596550
    [Abstract] [Full Text] [Related]

  • 18. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
    Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, Nissen C, Geis S.
    Am J Gastroenterol; 1989 Jun 29; 84(6):633-6. PubMed ID: 2499187
    [Abstract] [Full Text] [Related]

  • 19. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 20. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI.
    N Engl J Med; 1996 May 30; 334(22):1435-9. PubMed ID: 8618582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.